Jonathan Todd Garland
Chief Commercial Officer, Cytek Biosciences, Inc.
Companies
- NanoString TechnologiesChief Commercial Officer Aug 28, 2023 to May 8, 20241
- Cytek Biosciences, Inc.Chief Commercial Officer Apr 27, 2022 to Aug 21, 20232
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Cytek Biosciences, Inc. CTKB8,763 shares3$45.9K at $5.24Aug 18, 2023
NanoString Technologies200,000 shares4May 6, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- May 6, 2024Exercised options 200,000 shares of NanoString Technologies4
- Aug 18, 2023Shares withheld for tax 1,076 shares at $8.46 of Cytek Biosciences, Inc.3
- Aug 18, 2023Exercised options 2,761 shares of Cytek Biosciences, Inc.3
- Aug 18, 2023Shares withheld for tax 760 shares at $8.46 of Cytek Biosciences, Inc.3
- Aug 18, 2023Exercised options 1,951 shares of Cytek Biosciences, Inc.3
- May 18, 2023Shares withheld for tax 717 shares at $6.69 of Cytek Biosciences, Inc.5
- May 18, 2023Exercised options 1,840 shares of Cytek Biosciences, Inc.5
- May 18, 2023Shares withheld for tax 3,040 shares at $6.69 of Cytek Biosciences, Inc.5
- May 18, 2023Exercised options 7,804 shares of Cytek Biosciences, Inc.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed May 19, 2023